Exact Sciences ROCE 2024

Exact Sciences Aktienanalyse

What does Exact Sciences do?

Exact Sciences Corp is a US-based company specializing in the development, manufacturing, and marketing of diagnostics. It was founded in 1995 by Kevin T. Conroy and is headquartered in Madison, Wisconsin. The company's main focus is on cancer diagnostics. It has developed an innovative test called the Cologuard test, which is a simple, non-invasive method for detecting colorectal cancer. The test can provide accurate results by analyzing a stool sample from the patient. The Cologuard test is FDA approved and recommended by physicians in the US. Exact Sciences has also developed an extensive portfolio of liquid biopsy tests, which can help detect cancer in its early stages by identifying changes in the patient's blood. The company aims to expand its position in the market for non-invasive cancer diagnostics. Originally founded as an oncology diagnostics company specializing in the development of tests for early tumor detection, Exact Sciences expanded its focus to colorectal cancer diagnostics in 2009 after acquiring the rights to a patented biomarker. The company has experienced rapid growth in recent years and has become a leader in the field of non-invasive cancer diagnostics. It has made several acquisitions, including the acquisition of Genomic Health, a provider of cancer diagnostics and molecular tests. Exact Sciences is divided into two business segments: 1. Diagnostics Exact Sciences develops and distributes diagnostics for the detection of various forms of cancer. The company has a range of products on the market, including: - Cologuard: A test for detecting colorectal cancer - Oncotype DX: A test for detecting various types of breast cancer - Oncotype MAP: A test for detecting colorectal and gastric cancer - Oncotype IQ: A platform for detecting various types of cancer 2. Research and Development Exact Sciences also conducts research and development in the field of cancer diagnostics. The company is working on developing tests for detecting many types of cancer in their early stages. It has also formed partnerships with other companies and organizations to support its research in this field. In conclusion, Exact Sciences Corp is an innovative company specializing in the development of diagnostics for the detection of various types of cancer. The company has achieved a strong market position in non-invasive cancer diagnostics and aims to further expand its product range. With the Cologuard test and its other diagnostics, the company has saved many lives and will continue to contribute to the early detection and treatment of cancer in the future. Exact Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Exact Sciences's Return on Capital Employed (ROCE)

Exact Sciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Exact Sciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Exact Sciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Exact Sciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Exact Sciences stock

What is the ROCE (Return on Capital Employed) of Exact Sciences this year?

The ROCE of Exact Sciences is -0.07 undefined this year.

How has the ROCE (Return on Capital Employed) of Exact Sciences developed compared to the previous year?

The ROCE of Exact Sciences has increased by -64.08% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Exact Sciences?

A high Return on Capital Employed (ROCE) indicates that Exact Sciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Exact Sciences?

A low ROCE (Return on Capital Employed) can indicate that Exact Sciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Exact Sciences impact the company?

An increase in the ROCE of Exact Sciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Exact Sciences affect the company?

A decrease in ROCE of Exact Sciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Exact Sciences?

Some factors that can affect Exact Sciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Exact Sciences so important for investors?

The ROCE of Exact Sciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Exact Sciences take to improve the ROCE?

To improve the ROCE, Exact Sciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Exact Sciences pay?

Over the past 12 months, Exact Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Exact Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Exact Sciences?

The current dividend yield of Exact Sciences is .

When does Exact Sciences pay dividends?

Exact Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Exact Sciences?

Exact Sciences paid dividends every year for the past 0 years.

What is the dividend of Exact Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Exact Sciences located?

Exact Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Exact Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Exact Sciences from 10/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/7/2024.

When did Exact Sciences pay the last dividend?

The last dividend was paid out on 10/7/2024.

What was the dividend of Exact Sciences in the year 2023?

In the year 2023, Exact Sciences distributed 0 USD as dividends.

In which currency does Exact Sciences pay out the dividend?

The dividends of Exact Sciences are distributed in USD.